These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10724414)

  • 1. Needs for radioactivity standards and measurements in the life sciences.
    Coursey BM
    Appl Radiat Isot; 2000 Mar; 52(3):609-14. PubMed ID: 10724414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unconventional nuclides for radiopharmaceuticals.
    Holland JP; Williamson MJ; Lewis JS
    Mol Imaging; 2010 Feb; 9(1):1-20. PubMed ID: 20128994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National radioactivity standards for beta-emitting radionuclides used in intravascular brachytherapy.
    Coursey BM; Collé R; Zimmerman BE; Cessna JT; Golas DB
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):207-16. PubMed ID: 9588935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and future needs for standards of radionuclides used in positron emission tomography.
    Zimmerman BE
    Appl Radiat Isot; 2013 Jun; 76():31-7. PubMed ID: 23078834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a national metrology network of radionuclides used in nuclear medicine.
    dos Santos JA; Iwahara A; Nícoli IG; Corrêa RS; Alabarse FG; dos Santos CE; Xavier AM; Garcia EJ; Tauhata L; Lopes RT
    Appl Radiat Isot; 2006; 64(10-11):1114-8. PubMed ID: 16549360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
    Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
    Curr Radiopharm; 2017; 10(1):6-15. PubMed ID: 28034291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on 'dose calibrator' settings for nuclides used in nuclear medicine.
    Bergeron DE; Cessna JT
    Nucl Med Commun; 2018 Jun; 39(6):500-504. PubMed ID: 29596133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there life after technetium: what is the potential for developing new broad-based radionuclides?
    Srivastava SC
    Semin Nucl Med; 1996 Apr; 26(2):119-31. PubMed ID: 8723506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic and nanotheranostic probes in nuclear medicine.
    Drude N; Tienken L; Mottaghy FM
    Methods; 2017 Nov; 130():14-22. PubMed ID: 28698069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18.
    Coenen HH; Ermert J
    Nucl Med Biol; 2021 Jan; 92():241-269. PubMed ID: 32900582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
    Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
    Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel radionuclides for medical applications.
    Qaim SM; Spahn I
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):126-140. PubMed ID: 29110328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of fifteen years on metrological supervision of radionuclide calibrators used in nuclear medicine.
    Szörényi A; Vágvölgyi J; Zsinka A
    Appl Radiat Isot; 1998; 49(9-11):1459-61. PubMed ID: 9699295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
    Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
    Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET with non-standard nuclides.
    Hao G; Singh AN; Liu W; Sun X
    Curr Top Med Chem; 2010; 10(11):1096-112. PubMed ID: 20388114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear data for production and medical application of radionuclides: Present status and future needs.
    Qaim SM
    Nucl Med Biol; 2017 Jan; 44():31-49. PubMed ID: 27821344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.